Navigation Links
BD to Present at Investor Healthcare Conferences
Date:8/27/2008

FRANKLIN LAKES, N.J., Aug. 27 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it would present at the following investor healthcare conferences:

Thomas Weisel Healthcare Conference 2008

September 4, 2008

1:30 p.m. EDT

Morgan Stanley Global Healthcare Unplugged Conference

September 9, 2008

8:00 a.m. EDT

A live webcast of BD's presentations can be accessed from the BD corporate website at http://www.bd.com/investors. They will be available for replay for a period of seven days.

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

For more information, please visit http://www.bd.com.


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York
2. Thermage, Inc. to Present at the 2008 Thomas Weisel Partners Healthcare Conference
3. Nile Therapeutics to Present at BioCenturys NewsMakers in the Biotech Industry Conference
4. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
5. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
6. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
7. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
9. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
10. Cepheid to Webcast Upcoming Financial Presentations
11. Duska Therapeutics to Present at Noble Financial Equity M.A.D. MAX Conference on Tuesday, August 19th at 1:30 p.m. PDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 zFlo Motion , a US ... an exciting product from a new partner. STT-Systems ... the past 15 years, with offerings in the optical-motion capture, ... IMU system (inertial measurement unit), iSen, is opening eyes around ...
(Date:1/22/2015)... Diagenode, Inc., a leading global ... and complete solutions for epigenetics research, recently launched ... the need for manual processing. The new ChIPettor ... of histones or transcription factors and a semi-automated ...
(Date:1/22/2015)... GenoSpace , a precision medicine software company that has developed ... of genomic, imaging and other biomedical data in research and ... , CEO of Aspera, an IBM Company, to its board ... "We are pleased to welcome Michelle ...
(Date:12/24/2014)... , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: ... areas, announced the closing of an underwritten public offering of ... to an aggregate 3,500,000 shares of common stock, at an ... The warrants have a per share exercise price of $5.00, ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... FRANCISCO, Calif., May 5 Rigel Pharmaceuticals, Inc. (Nasdaq: ... quarter ended March 31, 2009.For the first quarter of 2009, ... per share, compared to a net loss of $27.3 million, ... Weighted average shares outstanding for the first quarters of 2009 ...
... Uveitis, or inflammation within the eye, is a ... loss roughly comparable to that caused by diabetes. ... program in uveitis, the LUMINATE trials sponsored by ... voclosporin oral capsule) to significantly improve this chronic ...
... The Arcas Group, a leading life-sciences marketing ... as Executive Vice President. He will assume responsibility for ... as President of Imedex, Inc."Stefan is an experienced executive ... our company," said Founder and President Jan Heybroek. ...
Cached Biology Technology:Rigel Announces First Quarter 2009 Financial Results 2Rigel Announces First Quarter 2009 Financial Results 3Rigel Announces First Quarter 2009 Financial Results 4Rigel Announces First Quarter 2009 Financial Results 5First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease 2First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease 3First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease 4The Arcas Group Appoints Executive Vice President 2
(Date:1/22/2015)... Jan. 16, 2015  A man-made form of insulin delivered ... mental capabilities in adults with mild cognitive impairment and ... by researchers at Wake Forest Baptist Medical Center. ... amnesic mild cognitive impairment (MCI) or mild to moderate ...
(Date:1/22/2015)... NEW YORK and POINT ROBERTS, Washington ... global news source covering leading sectors including technology and tech ... Personal Privacy marketplace featuring master pickpocket and security consultant ... wallet is stolen and talks about the Wocket™ biometric smart ...
(Date:1/22/2015)... , Europe,s most ... Patent Office to present a video retrospective of the most exciting ... Christofer Toumazou and Sophie Wilson   ... the Award   Starting on 22 January 2015 on   ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3
... corn, 1 + 1 = more than 2: The offspring ... of their parents. Characterizing the gene-level variability that leads to ... our ability to custom-tailor crops for specific traits, such as ... for biomass fuel. With help from the newly ...
... A team of researchers at Louisiana Tech University ... a natural herbicide against giant salvinia. Giant salvinia ... block all sunlight penetration into bodies of water, altering ... that giant salvinia can double in size every three ...
... - A new study of maize has identified thousands of ... techniques may allow breeders and researchers to use this genetic ... were not easily possible before. Publishing in the Nov. ... and first author are at Cornell, have identified the first ...
Cached Biology News:U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2Microorganism may provide key to combating giant salvinia throughout Louisiana 2New map of variation in maize genetics holds promise for developing new varieties 2
... Lipid adsorption and clarification reagent; Ideal ... purification of antibodies, proteins, nucleic acids, ... negligible cross-reactivity, and improves downstream processing; ... solid-phase, non-ionic adsorbent supplied as a ...
... is designed to stabilize the biomolecules ... storage. There are neither animal ... is a convenient 10 times solution ... superior to other traditional lyophilizing additives ...
... is the only Gradient thermal cycler which enables ... of a screen. ,Wide linear gradient - ... with an amazing range of,30C. Protocols can be ... - The Touchgene Gradient incorporates a large, 115 ...
... is Tecans open platform for clinical diagnostic ... and performance in the clinical diagnostic and ... flexible barcode reading and sample traceability as ... system complies with the IVD-Directive* established in ...
Biology Products: